Brief: Aadi Bioscience Q2 Pretax Profit USD -17.971 Mln

Whitehawk Therapeutics

09/08/2023 13:07

Aug 9 (Reuters) - Aadi Bioscience Q2 net income USD -17.971 million.
* Q2 pretax profit USD -17.971 million
* Q2 operating income USD -19.545 million
* Q2 operating expenses USD 25.747 million
* Q2 product sales USD 6.202 million